Latest
By Mike Harris / Monday, February 5th, 2024 / Central Coast, Health Care & Life Science, Latest news, Subscriber content, Technology / Comments Off on Dignity Health’s new patient care tech takes off
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latest
By Mike Harris / Wednesday, January 31st, 2024 / Central Coast, Health Care & Life Science, Nonprofits, Santa Barbara County, Top Stories, Top Story / Comments Off on Greater Central Coast becomes Sutter Health’s sixth community market
Sutter Health, a Sacramento-based nonprofit integrated health system, announced on Jan. 31 that its sixth community-based market will be the Greater Central Coast. The market will be anchored by Sansum Clinic, a 103-year-old nonprofit outpatient healthcare organization based in Santa Barbara, which officially became part of Sutter Health in October. “Our community-based markets allow us Read More →
Latest
By Amber Hair / Monday, January 8th, 2024 / Central Coast, Health Care & Life Science, Latest news, left, Subscriber content / Comments Off on Area hospital leaders discuss goals in ’24
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latest
By Jorge Mercado / Tuesday, January 2nd, 2024 / Central Coast, Health Care & Life Science, Latest news, Top Stories, Top Story / Comments Off on MannKind inks royalty purchase agreement for up to $200M
Westlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →
Latest
By Jorge Mercado / Friday, December 22nd, 2023 / Health Care & Life Science, Latest news, Subscriber content, Top Stories, Top Story, Tri-County Economy / Comments Off on Arcutis’ treatment gets additional FDA approval
Westlake Village-based Arcutis Biotherapeutics announced that its main treatment option, Zoryve, received approval from the U.S. Drug and Food Administration for treating a skin condition called seborrheic dermatitis, the company announced on Dec. 15 It is the second FDA approval received by Arcutis’ Zoryve, being approved to be used in individuals nine years of age Read More →
Latest
By Jorge Mercado / Thursday, December 21st, 2023 / Health Care & Life Science, Latest news, middle, Subscriber content / Comments Off on Cottage, independent physicians partner to open new surgery center
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.